The board of directors of Clover Biopharmaceuticals, Ltd. announced that it received a resignation letter from Mr. Ting XIAO ("Mr. Xiao") on April 22, 2022 to resign as a non-executive Director with effect from April 22, 2022. Since Mr. Xiao resigned as a non-executive Director, he ceases to be a member of the audit committee of the Company (the "Audit Committee"). Mr. Xiao tendered his resignation to focus on other business priorities.

The Board would like to announce that with effect from April 22, 2022, Mr. Dong LYU (), a non-executive Director, has been appointed as a member of the Audit Committee.